• Iontas Enters Licensing Agreement with Bristol Myers Squibb contractpharma
    October 16, 2020
    ​Iontas Limited, a biotechnology company focused on antibody discovery and technology development, has entered into a licensing agreement with Bristol Myers Squibb Company regarding the company’s proprietary mammalian display.
PharmaSources Customer Service